Barclays PLC Quidel Ortho Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Quidel Ortho Corp stock. As of the latest transaction made, Barclays PLC holds 28,257 shares of QDEL stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,257

Previous 28,257 -0.0%

Holding current value

$1.27 Million

Previous $1.29 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$29.96 - $46.4 $1.26 Million - $1.95 Million	-41,945 Reduced 59.75%	28,257 $1.29 Million
Q2 2024 Aug 14, 2024	BUY	$32.9 - $47.0 $398,221 - $568,888	12,104 Added 20.83%	70,202 $2.33 Million
Q1 2024 May 15, 2024	BUY	$41.76 - $74.73 $636,046 - $1.14 Million	15,231 Added 35.53%	58,098 $2.78 Million
Q4 2023 Feb 15, 2024	BUY	$58.16 - $75.44 $988,836 - $1.28 Million	17,002 Added 65.73%	42,867 $3.16 Million
Q3 2023 Nov 07, 2023	SELL	$70.9 - $88.63 $483,750 - $604,722	-6,823 Reduced 20.87%	25,865 $1.89 Million
Q2 2023 Aug 03, 2023	BUY	$81.09 - $94.16 $682,372 - $792,356	8,415 Added 34.67%	32,688 $2.71 Million
Q1 2023 May 04, 2023	BUY	$82.98 - $91.46 $1.38 Million - $1.52 Million	16,668 Added 219.17%	24,273 $2.16 Million
Q4 2022 Feb 13, 2023	SELL	$66.93 - $97.5 $1.64 Million - $2.39 Million	-24,555 Reduced 76.35%	7,605 $651,000
Q3 2022 Nov 03, 2022	BUY	$69.86 - $107.63 $603,380 - $929,600	8,637 Added 36.72%	32,160 $2.3 Million
Q2 2022 Aug 12, 2022	BUY	$89.06 - $117.64 $2.09 Million - $2.77 Million	23,523 New	23,523 $2.29 Million

Others Institutions Holding QDEL

# of Institutions

291

Shares Held

67.5M

Call Options Held

337K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $3B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account